Patrizio Armeni

Associate Professor of Practice
Knowledge groupGovernment, Health and Not for Profit
Research domainsHealth Economics and HTA
Teaching domainsEconomic Evaluations of Drugs, Health Technology Assessment, Policy Impact Analysis, Real-World Data and Real-World Evidence, Self-Leadership
Patrizio Armeni

Biography

Patrizio Armeni is Associate Professor of Practice in Government, Health and Not for Profit at SDA Bocconi School of Management.

Patrizio’s collaboration with SDA Bocconi started in 2009. He has gradually widened the scope of his research and teaching which began withthe Osservatorio Farmaci (Pharmaceutical Observatory) and went on to include, over time, other research areas related to public management, with a particular focus on the healthcare sector. His knowledge of healthcare organizations has awakened his interest in studying organizational behaviors of individuals and teams and led him to adopt   an educational approach based on the daily practice of ethical principles in the workplace (leadership in practice).

He has directed various executive programs for employees of pharmaceutical and medical device companies and has coordinated several sponsored educational programs dedicated to physicians and other healthcare and public sector professionals. He supervises a category of open market courses including programs dedicated to the interaction between the national health service and technology providers (pharma, medical devices, services). He also teaches «Public Management» and «Innovation and competition in life science»  at undergraduate level, and several courses on national and international master programs: «Economics of healthcare organizations», «Pharmaceutical policy», «Economic Evaluations - advanced» and «Evidence-based health policy evaluation», «Policy Evaluation».

He coordinates the research area «Health Economics & HTA» at CERGAS (Center for Research on Health and Social Care Management) at SDA Bocconi. His current research activity is focused on three themes: 1) economic evaluations of healthcare technologies (cost-effectiveness, cost-utility and budget impact analysis) and related methodological developments founded on the pillar of value-based healthcare; 2) analysis and support for policymakers for public policy design and implementation; 3) analysis of pharmaceutical and health technology markets in terms of performance, innovation and reaction to public policies. He has published several articles in international peer-reviewed journals and is the author of a number of chapters in monographic works. Since 2009 he has authored the chapter on healthcare expenditure in the OASI (Observatory on Healthcare Organizations and Policies in Italy) report, the leading annual Italian publication on issues relating to the healthcare system. He is member of the editorial board of the OASI report. Since 2020 he was appointed as director of operation of the newborn “LIFT” Lab dedicated to the convergence between digital innovation and life sciences.

Patrizio’s production and diffusion of knowledge is coupled with frequent participation as a speaker in international and national congresses and conferences. He serves as an expert on advisory boards for companies operating in the pharmaceutical / medical.

Recent Publications

Download
  • 2025
    Intelligenza artificiale in sanità: Europa al test tra regolazione e spinta verso l’innovazione
    ARMENI, P., "Intelligenza artificiale in sanità: Europa al test tra regolazione e spinta verso l’innovazione", Sanità. Il Sole 24 ore, 29 May 2025
  • 2025
    The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States
    ARSENAULT, C., S. RAVISHANKAR, T. LEWIS, P. ARMENI, K. CROKE, S. V. DOUBOVA, M. MCKEE, R. TARRICONE, M. E. KRUK, "The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States", Vaccine, 2025, vol. 54, pp. 127134
  • 2025
    Politiche del farmaco: un approfondimento sull’innovatività terapeutica
    ARMENI, P., L. CAVALLARO, F. COSTA, M. OTTO, "Politiche del farmaco: un approfondimento sull’innovatività terapeutica" in Rapporto OASI 2025., CERGAS (Ed.), Egea, chap. 8, 2025
  • 2024
    Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries
    ARSENAULT, C., T. P. LEWIS, N. R. KAPOOR, E. A. OKIRO, H. H. LESLIE, P. ARMENI, P. JARHYAN, S. V. DOUBOVA, K. D. WRIGHT, A. ARYAL, S. KOUNNAVONG, S. MOHAN, E. ODIPO, H.-Y. LEE, J. SHIN, W. AYELE, J. MEDINA-RANILLA, L. ESPINOZA-PAJUELO, A. DERSEH MEBRATIE, E. GARCÍA ELORRIO, A. MAZZONI, J. OH, G. K. STEELFISHER, R. TARRICONE, M. E. KRUK, "Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries", The Lancet Global Health, 2024, vol. 12, no. 1, pp. e156-e165
  • 2024
    Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy
    ROGNONI, C., D. LORUSSO, F. COSTA, P. ARMENI, "Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy", Advances in Therapy, 2024, vol. 41, no. 4, pp. 1385-1400
  • 2024
    Economic evaluation of two therapeutic sequences in the first-line treatment of moderate to severe active ulcerative rectocolitis in Italy
    ARMENI, P., E. COMPAGNUCCI, G. FIORINO, V. LOLLI, G. MAZZONE, A. ORLANDO, M. PRINCIPI, R. RAVASIO, F. RIZZELLO, E. V. SAVARINO, F. TOMBARI, "Economic evaluation of two therapeutic sequences in the first-line treatment of moderate to severe active ulcerative rectocolitis in Italy", AboutOpen, 2024, vol. 11, no. 1, pp. 21-29
  • 2024
    Exploring the potential of digital therapeutics: An assessment of progress and promise
    ARMENI, P., I. POLAT, L. DE ROSSI, L. DIAFERIA, S. MEREGALLI, A. GATTI, "Exploring the potential of digital therapeutics: An assessment of progress and promise", Digital Health, 2024, vol. 10
  • 2024
    Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment
    BORSOI, L., F. COSTA, C. MILANO, G. SEGANTIN, P. GHIA, P. ARMENI, "Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment", Leukemia & Lymphoma, 2024, vol. 65, no. 11, pp. 1565-1575
  • 2024
    Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes
    PETRUCCI, M. T., S. BRINGHEN, C. ENTRALA CEREZO, J. MENDES, P. ARMENI, "Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes", Critical Reviews in Oncology/Hematology, 2024, vol. 29, no. 1
  • 2024
    Politiche del farmaco: approfondimento sul Value Framework per i farmaci
    ARMENI, P., L. CAVALLARO, F. COSTA, F. MALANDRINI, M. OTTO, "Politiche del farmaco: approfondimento sul Value Framework per i farmaci" in Rapporto OASI 2024., CERGAS (Ed.), Egea, chap. 8, pp. 333-362, 2024

You have seen 10 out of 139 items

Grants & Honors

  • Premio ViviSalute, ViviSalute Lombardia, 2016

  • Best Paper in Healthcare Management, AIES - Italian Health Economics Association, 2015

  • Best Paper by Young Researchers, AIES - Italian Health Economics Association, 2010